Skip to content

Effects of Home-based Physical Activity in Saudi Arabian Type-2 Diabetes Mellitus Patients.

Effects of a Home-based Physical Activity Programme on Blood Biomarkers and Health-related Quality of Life Indices in Saudi Arabian Type-2 Diabetes Mellitus Patients: a Pilot Randomised Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04937296
Enrollment
62
Registered
2021-06-24
Start date
2022-01-12
Completion date
2023-06-01
Last updated
2023-06-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Type 2

Brief summary

The World Health Organization ranks Saudi Arabia as having the 7th highest rate of type-2 diabetes in the world. This therefore makes diabetes the most challenging health problem facing Saudi Arabia. Importantly, physical activity has been shown to improve disease symptoms and overall health in patients with type-2 diabetes. However, findings relating to the prevalence of physical inactivity in the Saudi population confirm that a sedentary lifestyle is on the rise, within physical inactivity levels in adults being 80.5%. Therefore, interventions aimed at reducing physical inactivity using bespoke modalities pertinent to Saudi Arabia are clearly warranted. The purpose of this research project is to undertake a feasibility randomised control trial, examining the effects of a 12-week home-based physical activity programme on HbA1c, blood lipids, fasting glucose and other indices of health-related quality of life in Saudi Arabian adults with type-2 diabetes.

Interventions

BEHAVIORALPhysical activity

Participants will be asked to perform resistance exercises 3-times a week on alternating days for 12 weeks. Exercises will be performed with a TheraBand and will include the squat, lunge, press-up, cross body reach, reverse fly, lateral raise, biceps curl, triceps extension, frontal raise and bridge. In addition to the resistance exercises, the participants will perform aerobic exercise. They will be asked to download a specific exercise app to record the number of steps on day 1 of the intervention and participants who do not possess the required phone technology will be provided with a pedometer. They then will be asked to add 2000 steps on to their daily steps; this amount will then become their daily step goal. Once they have reached this goal on 4 out of 5 days, they will be asked to increase their new step step goal by an extra 500 per day.

OTHERUsual care

Usual care.

Sponsors

University of Hertfordshire
CollaboratorOTHER
University of Jazan
CollaboratorOTHER_GOV
Jonathan Sinclair
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Clinically established diagnosis of type-2 diabetes for at least 12 months * Previously sedentary * Knowledgeable about hypoglycemia * Aged over 18 years * Capacity to give informed consent.

Exclusion criteria

* Cognitive impairment precluding consent or participation * Pregnancy * Additional medical conditions that prevent safe physical activity (e.g. severe arthritis or advanced heart failure) * Enrolment in any other clinical trial designed to influence type-2 diabetes symptoms.

Design outcomes

Primary

MeasureTime frameDescription
HBA1c (Glycated hemoglobin)BaselineGlycated hemoglobin is a form of hemoglobin that is chemically linked to a sugar. This parameter will be obtained via a venous blood sample.

Secondary

MeasureTime frameDescription
Patient Health Questionnaire-9 (PHQ-9)BaselineThe Patient Health Questionnaire-9 (PHQ-9) is the depression module, which has nine questions ranging from 0 (not at all) to 3 (nearly every day). The scoring is interpreted as 0-4 no depression symptoms, 5-9 mild, 10-14 moderate, 15-19 moderately severe, 20-27 severe depression symptoms.
Pittsburgh Sleep Quality Index (PSQI)BaselineThe Pittsburgh Sleep Quality Index (PSQI) is a self-report questionnaire that assesses sleep quality. The component scores are summed to produce a global score (range 0 to 21). Higher scores indicate worse sleep quality.
Physical fitnessBaselinePhysical fitness will be examined via the Chester Step test.
Fasting glucoseBaselineFasting glucose levels will be examined via a venous blood sample.
Systolic blood pressureBaselineSystolic blood pressure using blood pressure monitor with blood pressure cuff on the arm.
WHO Well-Being Index (WHO-5)BaselineThe World Health Organisation- Five Well-Being Index (WHO-5) is a short self-reported measure of current mental wellbeing. A score of 0 represents the worst imaginable well-being and 100 represents the best imaginable well-being.
Lipid profileBaselineA full lipid profile will be undertaken this involves Low-density lipoprotein (LDL), High-density lipoprotein (HDL), Triglycerides and Total cholesterol levels. This will be examined via a venous blood sample.
Body massBaselineBody mass in kg measured via an electric scale.
Body mass indexBaselineBody mass index will be quantified using the standard body mass index equation using measures of body mass and stature.
Triglyceride-glucose indexBaselineThe triglyceride-glucose index will be calculated using a logarithm of the fasting triglyceride and glucose indices.
Diastolic blood pressureBaselineDiastolic blood pressure using blood pressure monitor with blood pressure cuff on the arm.

Countries

Saudi Arabia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 12, 2026